Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)

Sichuan Biokin Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Sichuan Biokin Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 78.32 billion. The enterprise value is 74.90 billion.

Market Cap	78.32B
Enterprise Value	74.90B

Important Dates

The last earnings date was Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Sichuan Biokin Pharmaceutical Co.,Ltd. has 401.00 million shares outstanding. The number of shares has increased by 1.81% in one year.

Current Share Class	n/a
Shares Outstanding	401.00M
Shares Change (YoY)	+1.81%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	77.04%
Owned by Institutions (%)	10.47%
Float	61.75M

Valuation Ratios

The trailing PE ratio is 20.52 and the forward PE ratio is 20.77.

PE Ratio	20.52
Forward PE	20.77
PS Ratio	13.33
PB Ratio	18.46
P/TBV Ratio	n/a
P/FCF Ratio	18.26
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.29, with an EV/FCF ratio of 17.46.

EV / Earnings	19.71
EV / Sales	12.81
EV / EBITDA	18.29
EV / EBIT	18.58
EV / FCF	17.46

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.37.

Current Ratio	2.97
Quick Ratio	2.46
Debt / Equity	0.37
Debt / EBITDA	0.38
Debt / FCF	0.36
Interest Coverage	118.61

Financial Efficiency

Return on equity (ROE) is 163.15% and return on invested capital (ROIC) is 77.02%.

Return on Equity (ROE)	163.15%
Return on Assets (ROA)	60.19%
Return on Capital (ROIC)	77.02%
Revenue Per Employee	2.80M
Profits Per Employee	1.82M
Employee Count	2,086
Asset Turnover	1.40
Inventory Turnover	1.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +90.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+90.63%
50-Day Moving Average	181.46
200-Day Moving Average	162.04
Relative Strength Index (RSI)	55.15
Average Volume (20 Days)	1,409,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sichuan Biokin Pharmaceutical Co.,Ltd. had revenue of CNY 5.85 billion and earned 3.80 billion in profits. Earnings per share was 9.52.

Revenue	5.85B
Gross Profit	5.57B
Operating Income	4.03B
Pretax Income	4.11B
Net Income	3.80B
EBITDA	4.09B
EBIT	4.03B
Earnings Per Share (EPS)	9.52

Balance Sheet

The company has 4.98 billion in cash and 1.55 billion in debt, giving a net cash position of 3.43 billion or 8.54 per share.

Cash & Cash Equivalents	4.98B
Total Debt	1.55B
Net Cash	3.43B
Net Cash Per Share	8.54
Equity (Book Value)	4.24B
Book Value Per Share	10.58
Working Capital	4.07B

Cash Flow

In the last 12 months, operating cash flow was 4.36 billion and capital expenditures -69.01 million, giving a free cash flow of 4.29 billion.

Operating Cash Flow	4.36B
Capital Expenditures	-69.01M
Free Cash Flow	4.29B
FCF Per Share	10.70

Margins

Gross margin is 95.33%, with operating and profit margins of 68.94% and 64.99%.

Gross Margin	95.33%
Operating Margin	68.94%
Pretax Margin	70.37%
Profit Margin	64.99%
EBITDA Margin	69.94%
EBIT Margin	68.94%
FCF Margin	73.38%

Dividends & Yields

Sichuan Biokin Pharmaceutical Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.82%
Buyback Yield	-1.81%
Shareholder Yield	-1.81%
Earnings Yield	4.87%
FCF Yield	5.48%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sichuan Biokin Pharmaceutical Co.,Ltd. has an Altman Z-Score of 16.6.

Altman Z-Score	16.6
Piotroski F-Score	n/a